Workflow #1996
✓ CompletedType: scraped_article_processing
Started: December 04, 2025 at 2:20:12 AM
Completed: December 04, 2025 at 12:35:42 PM
Completed in 615m 30s
Triggered by: ingestion
Job Pipeline
clean_markdown_article
✓ completed→
analyze_article
✓ completed→
extract_entities
✓ completed→
analyze_sentiment
⊘ skippedclean_markdown_article
✓ CompletedCompleted in 525m 0s
analyze_article
✓ CompletedPending
extract_entities
✓ CompletedPending
analyze_sentiment
⊘ SkippedSkipped
Workflow Context
title:FDA appoints Tracy Hoeg as acting director of drug evaluation center
source:Reuters
content:
Senior Advisor for Clinical Sciences at the FDA Tracy Beth Hoeg, MD, PhD, speaks at the meeting of the members of the Advisory Committee on Immunization Practices as the U.S. Centers for Disease Control and Prevention's (CDC) advisory panel for vaccines convenes, in Atlanta, Georgia, U.S. June 25, 2025. REUTERS/Megan Varner * Companies
* [U.S. Food and Drug Administration](/company/u-s-food-and-drug-administration/)
Follow
Dec 3 (Reuters) - The U.S. Food and Drug Administration said on Wednesday it has appointed Tracy Beth Hoeg as acting director of the Center for Drug Evaluation and Research, after the sudden [retirement](/business/healthcare-pharmaceuticals/newly-appointed-drug-evaluation-chief-set-leave-fda-stat-news-reports-2025-12-02/) of Richard Pazdur just weeks after he assumed the role.
Pazdur, the veteran oncology chief at the regulatory agency, took over the role on November 11, after George Tidmarsh resigned amid serious concerns about his personal conduct.
Sign up [here.](undefined?location=article-paragraph&redirectUrl=%2Fbusiness%2Fhealthcare-pharmaceuticals%2Ffda-appoints-tracy-heg-acting-director-drug-evaluation-segment-2025-12-04%2F)
The appointment of Hoeg, a COVID vaccine skeptic and close aide to FDA Commissioner Marty Makary, comes as U.S. Health Secretary Robert Kennedy Jr. makes stark changes at the agency.
"Dr. Hoeg is the right scientist to fully modernize CDER and finish the job of establishing a culture of cross-center coordination there," Makary said.
Hoeg assumes the role at a time when the U.S. health regulator has been making sweeping changes on vaccines.
A panel will vote this week on whether to delay [hepatitis B shots](/legal/litigation/us-vaccine-committee-vote-this-week-delay-hepatitis-b-shots-2025-12-02/) for most American children, a move that would be the most consequential change since the health secretary began remaking vaccine policy.
CDER is the FDA's largest and most important division, which regulates over-the-counter and most prescription drugs.
Hoeg, who opposed key U.S. health policies during the COVID-19 pandemic and questioned the use of some childhood vaccines, was named a special assistant to Makary in April.
A physician and epidemiologist, Hoeg has also practiced physical and interventional spine and sports medicine before joining the FDA as senior adviser for clinical sciences in the office of the commissioner and the Center for Biologics Evaluation and Research.
Both Hoeg and Makary expressed contrarian views on U.S. COVID policies, including opposition to mask requirements for children and universal vaccine mandates for the public, while supporting vaccination in general as a key public health measure.
Reporting by Sriparna Roy and Angela Christy in Bengaluru; Editing by Sherry Jacob-Phillips
Our Standards: [The Thomson Reuters Trust Principles., opens new tab](https://www.thomsonreuters.com/en/about-us/trust-principles.html)
* Suggested Topics:
* [Healthcare & Pharmaceuticals](/business/healthcare-pharmaceuticals/)
* [Regulatory Oversight](/sustainability/regulatory-oversight/)
* [Regulatory](/business/healthcare-pharmaceuticals/regulatory/)
* [Corporate Structure](/business/healthcare-pharmaceuticals/corporate-structure/)
* [Approvals](/business/healthcare-pharmaceuticals/approvals/)
Share
* X
* Facebook
* Linkedin
* Email
* Link
Read Next
---------
* ago[Healthcare & Pharmaceuticalscategory](/business/healthcare-pharmaceuticals/)
[Details of failed studies cast pall on Novo Nordisk's GLP-1 as Alzheimer's treatment](/business/healthcare-pharmaceuticals/details-failed-studies-cast-pall-novo-nordisks-glp-1-alzheimers-treatment-2025-12-04/)
[](/business/healthcare-pharmaceuticals/details-failed-studies-cast-pall-novo-nordisks-glp-1-alzheimers-treatment-2025-12-04/)
* ago[Healthcare & Pharmaceuticalscategory](/business/healthcare-pharmaceuticals/)
[FDA approves Axogen's nerve repair graft](/business/healthcare-pharmaceuticals/fda-approves-axogens-nerve-repair-graft-2025-12-03/)
[](/business/healthcare-pharmaceuticals/fda-approves-axogens-nerve-repair-graft-2025-12-03/)
* ago[Healthcare & Pharmaceuticalscategory](/business/healthcare-pharmaceuticals/)
[US FDA removes longtime director of over-the-counter drugs office](/business/healthcare-pharmaceuticals/us-fda-removes-longtime-director-over-the-counter-drugs-office-2025-12-03/)
[](/business/healthcare-pharmaceuticals/us-fda-removes-longtime-director-over-the-counter-drugs-office-2025-12-03/)
* ago[Healthcare & Pharmaceuticalscategory](/business/healthcare-pharmaceuticals/)
[Anabel's lost year illustrates the failings of Spain's breast cancer program](/business/healthcare-pharmaceuticals/anabels-lost-year-illustrates-failings-spains-breast-cancer-program-2025-12-03/)
[](/business/healthcare-pharmaceuticals/anabels-lost-year-illustrates-failings-spains-breast-cancer-program-2025-12-03/)
* ago[Healthcare & Pharmaceuticalscategory](/business/healthcare-pharmaceuticals/)
[Novo Nordisk gears up for December Ozempic launch in India, sources say](/business/healthcare-pharmaceuticals/novo-nordisk-gears-up-december-ozempic-launch-india-sources-say-2025-12-03/)
[](/business/healthcare-pharmaceuticals/novo-nordisk-gears-up-december-ozempic-launch-india-sources-say-2025-12-03/)
[](https://www.lseg.com/en/data-analytics/products/workspace?utm_source=reuters.com&utm_medium=articlebanner&utm_campaign=Reuters_ProductPage_Links)
----------------------
* [](/world/india/indian-rupee-rise-record-lows-us-trade-deal-key-recovery-2025-12-04/)
### [Indian rupee to rise from record lows, but US trade deal key for recovery](/world/india/indian-rupee-rise-record-lows-us-trade-deal-key-recovery-2025-12-04/)
[category](/world/) · December 4, 2025 · 2:14 AM UTC · ago
The Indian rupee will regain some lost ground against the U.S. dollar over the next three months, according to a Reuters poll of FX strategists, but a reversal in the currency's fortunes hinges upon India and the U.S. agreeing to a trade deal.
* [](/world/asia-pacific/dollar-weak-with-rate-cut-enthusiasm-intact-euro-7-week-high-2025-12-04/)
[category](/world/)[Dollar weak with rate-cut enthusiasm intact, euro at 7-week high](/world/asia-pacific/dollar-weak-with-rate-cut-enthusiasm-intact-euro-7-week-high-2025-12-04/)
1:43 AM UTC
* [](/sustainability/boards-policy-regulation/second-anz-proxy-advisor-recommends-vote-against-pay-report-2025-12-04/)
[Sustainabilitycategory](/sustainability/)[Second ANZ proxy advisor recommends vote against pay report](/sustainability/boards-policy-regulation/second-anz-proxy-advisor-recommends-vote-against-pay-report-2025-12-04/)
1:41 AM UTC
* [](/business/energy/oil-prices-firm-after-ukrainian-strikes-russian-oil-infrastructure-stalled-peace-2025-12-04/)
[Energycategory](/business/energy/)[Oil prices firm after Ukrainian strikes on Russian oil infrastructure, stalled peace talks](/business/energy/oil-prices-firm-after-ukrainian-strikes-russian-oil-infrastructure-stalled-peace-2025-12-04/)
1:27 AM UTC
* [](/business/tricolor-creditors-seek-probe-into-alleged-collateral-fraud-lender-conduct-2025-12-04/)
[Businesscategory](/business/)[Tricolor creditors seek probe into alleged collateral fraud, lender conduct](/business/tricolor-creditors-seek-probe-into-alleged-collateral-fraud-lender-conduct-2025-12-04/)
1:18 AM UTC
article_id:2872 →
content_type:article